Global Viral Vaccines Cdmo Market Size & Outlook, 2025-2033
Global viral vaccines cdmo market, 2021-2033 (US$M)
Related Markets
Global viral vaccines cdmo market highlights
- The global viral vaccines cdmo market generated a revenue of USD 2,234.0 million in 2024 and is expected to reach USD 7,387.7 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 15.1% by 2033.
- In terms of segment, attenuated vaccine accounted for a revenue of USD 901.0 million in 2024.
- Subunit Vaccines is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2033.
Global data book summary
| Market revenue in 2024 | USD 2,234.0 million |
| Market revenue in 2033 | USD 7,387.7 million |
| Growth rate | 15.1% (CAGR from 2025 to 2033) |
| Largest segment | Attenuated vaccine |
| Fastest growing segment | Subunit Vaccines |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Attenuated Vaccine, Inactivated Vaccine, DNA Vaccines, Subunit Vaccines |
Other key industry trends
- In terms of revenue, the North America accounted for 38.3% of the global viral vaccines cdmo market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, China is the fastest growing regional market and is projected to reach USD 535.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viral Vaccines CDMO Market Scope
Viral Vaccines CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| FUJIFILM Diosynth Biotechnologies | View profile | - | - | - |
| Recipharm AB | View profile | - | - | - |
| WuXi Biologics. | View profile | - | - | - |
| Thermo Fisher Scientific, Inc. | View profile | - | - | - |
| Catalent Pharma Solutions | View profile | 5001-10000 | Somerset, New Jersey, United States, North America | http://www.catalent.com |
| HALIX | View profile | 11-50 | Leiden, Zuid-Holland, The Netherlands, Europe | https://www.halix.nl |
| Batavia Biosciences | View profile | 101-250 | Leiden, Zuid-Holland, The Netherlands, Europe | http://www.bataviabiosciences.com/ |
| Alcami | View profile | 501-1000 | Wilmington, North Carolina, United States, North America | http://www.alcaminow.com |
| Samsung BioLogics | View profile | 1001-5000 | Incheon, Inch'on-jikhalsi, South Korea, Asia | https://www.samsungbiologics.com/ |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
Global viral vaccines cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to viral vaccines cdmo market will help companies and investors design strategic landscapes.
Attenuated vaccine was the largest segment with a revenue share of 40.33% in 2024. Horizon Databook has segmented the Global viral vaccines cdmo market based on attenuated vaccine, inactivated vaccine, dna vaccines, subunit vaccines covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Viral Vaccines CDMO Type Outlook (Revenue, USD Million, 2021-2033)
- Attenuated Vaccine
- Inactivated Vaccine
- DNA Vaccines
- Subunit Vaccines
- Global Viral Vaccines CDMO Service Outlook (Revenue, USD Million, 2021-2033)
- Formulation & Process Development
- Upstream Development
- Downstream Development
- Analytical Testing
- Fill-Finish Services
- Packaging & Labeling
- Others
- Formulation & Process Development
- Global Viral Vaccines CDMO Workflow Outlook (Revenue, USD Million, 2021-2033)
- Clinical
- Commercial
- Global Viral Vaccines CDMO End Use Outlook (Revenue, USD Million, 2021-2033)
- Biopharmaceutical Companies
- Academic and Research Institutes
- Others
Reasons to subscribe to Global viral vaccines cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global viral vaccines cdmo market databook
-
Our clientele includes a mix of viral vaccines cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global viral vaccines cdmo market , including forecasts for subscribers. This global databook contains high-level insights into Global viral vaccines cdmo market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global viral vaccines cdmo market size, by regions, 2021-2033 (US$M)
Top 10 countries: Viral vaccines cdmo market size, 2024 (US$M)
Global viral vaccines cdmo market share, by type, 2024 & 2033 (%, US$M)
Viral vaccines cdmo market: Opportunity assessment by country
Global viral vaccines cdmo market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
